Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
8
Bearish filings
16
Named actors
13
Disclosed $ (bull / bear)
$50.5M + 3 of unknown size / $49.0M + 6 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-20 | 5%+ holder (13G) Point72 Asset Management, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-08-19 | Chief Legal Officer Tousignant Jennifer | sold | $103K | SEC ↗ |
| 2026-08-19 | Chief Legal Officer Tousignant Jennifer | sold | $245K | SEC ↗ |
| 2026-08-19 | Officer (via Fidelity Brokerage Services LLC) Tousignant Jennifer | filed notice to sell | $348K | SEC ↗ |
| 2026-08-14 |
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 5%+ holder (13G) — reduced stake Deep Track Capital, LP |
| reduced its stake (13D/G amendment) |
| — |
| SEC ↗ |
| 2026-08-14 | Chief Medical Officer Tripuraneni Radhika | exercised options & held the shares | $528K | SEC ↗ |
| 2026-08-14 | 5%+ holder (13G) — reduced stake Kynam Capital Management, LP | reduced its stake (13D/G amendment) | — | SEC ↗ |
| 2026-06-26 | 5%+ holder (13G) Paradigm Biocapital Advisors LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-11 | Director Fairmount Funds Management LLC | bought | $20.0M | SEC ↗ |
| 2026-05-08 | 5%+ holder (13G) Deep Track Capital, LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-08 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-05-06 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-03-04 | Officer (via Fidelity Brokerage Services LLC) Mahoney Stephen F. | filed notice to sell | $224K | SEC ↗ |
| 2026-03-04 | Officer (via Fidelity Brokerage Services LLC) Harmon Seth | filed notice to sell | $61K | SEC ↗ |
| 2026-03-04 | Officer (via Fidelity Brokerage Services LLC) Tousignant Jennifer | filed notice to sell | $51K | SEC ↗ |
| 2026-03-04 | Officer (via Fidelity Brokerage Services LLC) Beetham Thomas W. | filed notice to sell | $92K | SEC ↗ |
| 2025-12-31 | Institution (13F) MAVERICK CAPITAL LTD | exited a position | $47.8M | — |
| 2025-12-31 | Chief Legal Officer Tousignant Jennifer | sold | $71K | SEC ↗ |
| 2025-12-31 | Officer (via Fidelity Brokerage Services LLC) Tousignant Jennifer | filed notice to sell | $71K | SEC ↗ |
| 2025-10-23 | Director Fairmount Funds Management LLC | bought | $10.0M | SEC ↗ |
| 2025-10-23 | Director Fairmount Healthcare Fund II L.P. | bought | $10.0M | SEC ↗ |
| 2025-10-23 | Director Fairmount Healthcare Fund II GP LLC | bought | $10.0M | SEC ↗ |
| 2025-10-23 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2025-10-21 | Issuer (share issuance) | priced an offering | — | SEC ↗ |